|Home | About | Journals | Submit | Contact Us | Français|
In most eukaryotic cells, tubulin is subjected to posttranslational glutamylation, a conserved modification of unclear function. The glutamyl side chains form as branches of the primary sequence glutamic acids in two biochemically distinct steps: initiation and elongation. The length of the glutamyl side chain is spatially controlled and microtubule type specific. Here, we probe the significance of the glutamyl side chain length regulation in vivo by overexpressing a potent side chain elongase enzyme, Ttll6Ap, in Tetrahymena. Overexpression of Ttll6Ap caused hyperelongation of glutamyl side chains on the tubulin of axonemal, cortical, and cytoplasmic microtubules. Strikingly, in the same cell, hyperelongation of glutamyl side chains stabilized cytoplasmic microtubules and destabilized axonemal microtubules. Our observations suggest that the cellular outcomes of glutamylation are mediated by spatially restricted tubulin interactors of diverse nature.
Microtubules are dynamic elements of the cytoskeleton that are assembled from heterodimers of α- and β-tubulin. Once assembled, tubulin subunits undergo several conserved posttranslational modifications (PTMs) that diversify the external and luminal surfaces of microtubules (51). Two tubulin PTMs, glycylation and glutamylation, collectively known as polymodifications, form peptide side chains that are attached to the γ-carboxyl groups of glutamic acids in the primary sequence of the C-terminal tails (CTTs) of α- and β-tubulin (14, 36). Glutamylated microtubules are abundant in projections of neurons (14), axonemes (8, 15, 17), and centrioles/basal bodies (5, 31) and are detectable in the mitotic spindle and on a subset of cytoplasmic network microtubules (1, 5). The modifying enzymes, tubulin glutamic acid ligases (tubulin E-ligases), belong to the family of proteins related to the tubulin tyrosine ligase (TTL), known as TTL-like (TTLL) proteins (22, 50, 53). Tubulin glutamylation appears to be important in vivo. A knockdown of the TTLL7 E-ligase mRNA in cultured neurons inhibits the outgrowth of neurites (20). A loss of PGs1, a protein associated with TTLL1 E-ligase (22, 37), disorganizes sperm axonemes in the mouse (11), and a morpholino knockdown of TTLL6 E-ligase expression in zebrafish inhibits the assembly of olfactory cilia (33). The biochemical consequences of tubulin glutamylation in vivo are poorly understood, but the emerging model is that this PTM regulates interactions between microtubules and microtubule-associated proteins (MAPs) (6, 7, 19, 27).
The ciliate Tetrahymena thermophila has 18 types of diverse microtubules that are all assembled in a single cell. Although most, if not all, of these microtubules are glutamylated, the length of glutamyl side chains is spatially regulated (8, 53). Minimal side chains composed of a single glutamic acid (monoglutamylation) are present on the cytoplasmic and nuclear microtubules, whereas elongated side chains are present on the basal bodies and axonemes (53). In Tetrahymena, Ttll6Ap is a β-tubulin-preferring E-ligase (22), with a strong if not exclusive, side chain elongating activity (50). Here, by overproducing Ttll6Ap in vivo, we explore the consequences of glutamyl side chain hyper-elongation. Unexpectedly, we show that in the same cells, hyperelongation of glutamyl side chains stabilizes cell body and destabilizes axonemal microtubules. The simplest explanation of these data is that, in vivo, the cellular outcomes of tubulin glutamylation are mediated by diverse microtubule type-specific MAPs. To our knowledge, we are first to report that excessive tubulin glutamylation can either stabilize or destabilize microtubules in the same cell.
Tetrahymena cells were grown in the SPP medium (18) supplied with the antibiotic-antimycotic mix (Invitrogen, Carlsbad, CA). To overexpress Ttll6Ap variants tagged at the N terminus with GFP, fragments of the coding region of TTLL6A were amplified with addition of MluI and BamHI sites at the 5′ and 3′ ends, respectively, and cloned into pMTT1-GFP plasmid (52). The primers are listed in Table S1 in the supplemental material. The transgenic strains were constructed and induced as described previously (22, 53).
GFP-Ttll6Ap-expressing cells were grown in SPP with 0.5 to 2.5 μg of CdCl2/ml for 2 to 4 h. For GFP-Ttll6Ap localization, a 10-μl drop of cells was placed on a coverslip, followed by the addition of 20 μl of 2% paraformaldehyde in PHEM buffer (43) and, after 20 s, the addition of 10 μl of 0.5% Triton X-100 in PHEM. The cells were subjected to immunofluorescence (22) with the following primary antibodies: 12G10, an anti-α-tubulin monoclonal antibody (MAb) (23) at 1:50; MAb ID5 (40), which in Tetrahymena is specific to polyglutamylated tubulin (53), at 1:50; poly(E) anti-polyglutamic acid antibodies (1:100) (44); TAP952, an anti-monoglycylated tubulin MAb (1:5,000) (9, 10); and 6-11 B-1, an anti-acetyl-K40 α-tubulin MAb (1:200) (28). The secondary goat antibodies were as follows: anti-mouse-FITC, anti-mouse-Cy3, anti-rabbit-Cy3, and anti-rabbit-Cy5 (Zymed) at 1:200 dilutions. Cells were viewed under either Leica TCS SP or Zeiss LSM 510 VIS/META confocal microscopes. To measure the length of the cilia, the cells were labeled with MAb 12G10, [and, in some experiments, double labeled with poly(E) antibodies]. Confocal images were recorded with a 0.8-μm distance between z-sections, and sets of two to four z-sections were merged. The lengths of the cilia were measured by using ImageJ 1.37. For transmission electron microscopy (TEM), the cells were prepared as described previously (24).
For a two-dimensional (2D) separation of tubulin isoforms, cytoskeletons were prepared as described previously (22) from uninduced or induced GFP-Ttll6Ap-expressing cells and washed with the lysis buffer without Triton X-100. A 100-μg portion of the cytoskeletons (15 μl) was separated by isoelectric focusing on 18-cm Immobiline dry strips (4.5-5.5), followed by SDS-PAGE (10%) and silver staining. For Western blots, total extracts from 5 × 103 cells (22) were separated by SDS-8% PAGE (22). The primary antibodies were used as follows at the indicated concentrations: 12G10 (1:10,000), poly(E) (1:2,000), GT335 anti-glutamylation MAb (1:1,000) (55), TAP952 (1:10,000), and 6-11 B-1 (1:10,000).
Ttll6Ap of Tetrahymena is a potent E-ligase (22) with strong side chain-elongating activity on β-tubulin (50). Here, we explore the consequences of deregulation of the glutamyl side chain length by overexpression of Ttll6Ap in Tetrahymena. We overexpressed Ttll6Ap as an N-terminal GFP fusion using the strong cadmium-dependent MTT1 promoter (22, 45). A Western blot with the anti-polyglutamic acid antibody, poly(E), which recognizes elongated glutamyl side chains (>= 3E), showed that overexpression of GFP-Ttll6Ap increased the levels of polyglutamylation of proteins in the tubulin size range, whereas the levels of other proteins recognized by the same antibody (likely glutamylated nontubulin proteins), remained unchanged (Fig. (Fig.1A).1A). 2D SDS-PAGE showed that overproduction of GFP-Ttll6Ap led to appearance of strings of highly acidic isoforms migrating near the main spots of α- and β-tubulin (Fig. 1B and C, arrows). The levels of tubulin glutamylation detected by GT335, an antibody that recognizes a glutamyl side chain of any length (55), were unchanged or slightly lower in overexpressing cells (Fig. (Fig.1A).1A). Thus, in vivo, overexpressed Ttll6Ap appears to have primarily a side chain-elongating activity on tubulin.
GFP-Ttll6Ap localized mainly to a subset of short, most likely assembling cilia (see Fig. S1A and B [arrows] in the supplemental material). Consistently, when GFP-Ttll6Ap was overproduced in cilium-regenerating cells, the transgenic protein was targeted to most if not all cilia (Fig. (Fig.1E).1E). Overproduction of increased duration (or increased strength) resulted in colocalization of GFP-Ttll6Ap to subcortical and cytoplasmic microtubules (Fig. (Fig.1D,1D, arrows), in addition to cilia (Fig. (Fig.1D,1D, arrowheads) (see also reference 22).
Overproduction of GFP-Ttll6Ap strongly increased the levels of tubulin polyglutamylation on ciliary, cell body, and nuclear microtubules (Fig. (Fig.22 and see Fig. S2 in the supplemental material). The pattern of accumulation of tubulin polyglutamylation was dependent on the time and strength of overexpression of GFP-Ttll6Ap (Fig. (Fig.1A1A and and2).2). A 1-h induction of GFP-Ttll6Ap with 2.5 μg of CdCl2/ml or induction for a longer time by a lower cadmium concentration increased the level of tubulin polyglutamylation mainly in assembling axonemes (Fig. 2A and B). This indicates that cilia are the primary site of the native Ttll6Ap activity. Functional studies agree with this hypothesis: deletion of TTLL6A and a closely related TTLL6F led to a loss of ciliary motility and deletion of additional paralogs (TTLL6B and 6D) led to shortening of cilia (S. Suryavanshi and J. Gaertig, unpublished data). The hyperglutamylated axonemes in GFP-Ttll6Ap cells were shorter than axonemes in untreated cells (Fig. (Fig.2B2B and see Fig. S2B1 to B3 in the supplemental material). With longer induction period or increased strength of induction (cadmium concentration), tubulin polyglutamylation accumulated on cortical and cytoplasmic microtubules (Fig. 2C and D [arrowheads] and Fig. 2E to G).
To determine which parts of Tll6Ap are required for ciliary localization and enzymatic activity, we overexpressed truncated variants of Ttll6Ap as GFP fusions (see Fig. S1and S3 in the supplemental material). The predicted Ttll6Ap is composed of 1,217 amino acids with the conserved TTL-like domain located between V395 and N703 (based on SMART prediction ). Truncations of the C-terminal portion of the protein beyond Q828 residue resulted in increased retention of the fusion protein in the cell body (see Fig. S1 in the supplemental material). On the other hand, the fragment R712-L1217 lacking the TTL-like domain was sufficient to target GFP to cilia (see Fig. S1H in the supplemental material). Thus, the R712-L1217 region contains determinants involved in targeting of Ttl6Ap to cilia.
Truncation of 240 amino acids on the N-terminal side and 390 amino acids on the C-terminal side of the TTL-like domain (GFP-Ttll6Ap-M241-Q828 variant) had an E-ligase activity in vivo (see Fig. S3A to D in the supplemental material). Further deletions on either the N- or C-terminal side (resulting in fragments E337-Q828, M241-E725, and A326-V929) abolished the E-ligase activity in vivo (see Fig. S3E in the supplemental material and data not shown). Therefore, among the tested variants, the M241-Q828 fragment is the smallest enzymatically active protein. The TTL homology domain is contained between V395 and N703. Thus, less conserved amino acids adjacent to the TTL-like homology domain contribute to the enzymatic activity, as seen earlier for mammalian E-ligases (50). The majority of GFP-Ttll6Ap-M241-Q828 was associated with cytoplasmic microtubules, and only weak signal was observed in growing cilia during the formation of new oral apparatus prior to cell division (see Fig. S1E [arrowhead] in the supplemental material). In vegetatively growing GFP-Ttll6Ap-M241-Q828-overexpressing cells, short hyperglutamylated cilia were rarely observed but bundles of hyperglutamylated cell body microtubules were abundant (see Fig. S3D in the supplemental material). In contrast to GFP-Ttll6Ap and GFP-Ttll6Ap-M241-V929-overexpressing cells that gradually loose motility (22), GFP-Ttll6Ap-M241-Q828-overexpressing cells remained motile (data not shown). Thus, GFP-Ttll6Ap M241-Q828 acts primarily in the cell body. We used truncated variants of GFP-Ttll6Ap to selectively drive tubulin hyperglutamylation in the cell body (see below). The growth rate of cells overexpressing either full-length or enzymatically active fragments of GFP-Ttll6Ap was reduced compared to wild-type cells treated with the same cadmium concentration (see Fig. S3G in the supplemental material), suggesting that hyperglutamylation of cell body microtubules is deleterious for cell growth.
In wild-type Tetrahymena cells, the length of the glutamyl side chains on tubulin is spatially regulated. The cell body microtubules (cytoplasmic, subcortical, and nuclear) have tubulin subunits with side chains limited to a single E (monoglutamylated) except for the postoral fiber microtubules that carry biglutamylated side chains (53). Within the cell cortex, axonemes and basal bodies contain mono- and polyglutamylated microtubules (with biglutamylated or longer side chains), whereas cortical bundles have side chains limited to a single E (53). Overproduction of GFP-Ttll6Ap resulted in the polyglutamylation of diverse microtubules in the cell body, which in wild-type cells are only monoglutamylated, including cytoplasmic network and nuclear microtubules (see Fig. S2C to L in the supplemental material). Moreover, in GFP-Ttll6Ap-overexpressing cells, anti-α-tubulin antibodies revealed abnormally thick bundles of subcortical and nuclear microtubules (Fig. 3C to G and see Fig. S2C to L in the supplemental material). In dividing cells, abnormally thick bundles of intramacronuclear microtubules were present around and within the cytoplasmic bridge connecting the future daughter cells (Fig. (Fig.3G,3G, arrow). Bundling of nuclear microtubules was especially apparent in the GFP-Ttll6Ap-M241-V929 cells, and this was likely due to the increased presence of this variant in the cell body (see Fig. S1D in the supplemental material; Fig. 3E and F, arrows). The increased abundance, bundling, and curvature of microtubules indicated that hyperglutamylated microtubules are excessively stable. For example, similar curved bundles of microtubules appear in Tetrahymena cells treated with the microtubule stabilizing drug, paclitaxel (16) (Fig. 3A and B) and in cells with a K350M mutation in β-tubulin that confers paclitaxel sensitivity (47). To probe the stability of cell body microtubules, we treated the wild-type and GFP-Ttll6Ap-overexpressing cells with the microtubule-destabilizing compounds, nocodazole (40 μM) and oryzalin (10 μM). Although these drugs caused rapid depolymerization of cytoplasmic microtubules in wild-type cells (Fig. 3H, H′, and J and data not shown for nocodazole), similarly treated GFP-Ttll6Ap-overexpressing cells retained abundant cell body microtubules (Fig. 3I, I′, and J). Next, we investigated the levels of α-tubulin K40 acetylation in GFP-Ttll6Ap-overproducing cells, since this PTM accumulates on long-lived microtubules (34). Although wild-type cells had a strong K40 acetylation signal that was limited to the stable microtubules of cell cortex and cilia, the GFP-Ttll6Ap-overproducing cells showed abundant K40 acetylation on cytoplasmic microtubules, a finding consistent with increased stability of these microtubules (Fig. (Fig.4).4). Cells overexpressing a variant of GFP-Ttll6Ap that lacks enzymatic activity due to a mutation in the catalytic domain (22) had a wild-type organization of cell body and cortical microtubules and a normal the pattern of K40 acetylation (data not shown). Thus, hyperelongation of glutamyl side chains stabilizes at least a subset of cell body microtubules.
GFP-Ttll6Ap-overproducing cells also had reduced levels of tubulin monoglycylation on stabilized cytoplasmic and cortical microtubules (Fig. (Fig.1A1A and see Fig. S4 in the supplemental material). Similar observations were made for tubulin polyglycylation (data not shown). We have previously documented that the two tubulin polymodifications, glutamylation and glycylation, inhibit each other, and we suggested that this mutual inhibition can be explained either by competition for the same modification sites or steric inhibition of adjacent sites (54). Overproduction of GFP-Ttll6Ap does not lead to an increase in the total number of glutamyl side chains on tubulin (based on Western blots with GT335 MAb that recognizes a side chain of any length [Fig. [Fig.1A]).1A]). Thus, it is more likely that elongation of glutamyl side chains sterically inhibits the activity of tubulin G-ligases (TTLL3 [21, 38, 54]) on adjacent polymodification sites.
GFP-Ttll6Ap-overexpressing cells contained both excessively short hyperglutamylated cilia (in which GFP-Ttll6Ap accumulates) and unaffected cilia (with a low GFP-Ttll6Ap signal; Fig. Fig.1D1D and Fig. S1A and B and S2B in the supplemental material). The short, hyperglutamylated cilia observed within 1 to 4 h after induction of GFP-Ttll6Ap overexpression could be assembling cilia that had failed to elongate or preexisting cilia that had undergone shortening (or both). Since mildly overproduced GFP-Ttll6Ap is preferentially targeted to assembling cilia (Fig. (Fig.1E),1E), hyperglutamylation could primarily affect axonemes during their assembly. To test this hypothesis, we deciliated wild-type and GFP-Ttll6Ap-overproducing cells and examined the lengths of the cilia during regeneration. While at 1 h after deciliation wild-type cells had regenerated cilia to 85% of the original length (4.32 ± 0.57 μm, n = 30), during the same period the GFP-Ttll6Ap-overexpressing cells regenerated significantly shorter cilia (1.07 ± 0.35 μm, n = 50 [Fig. 5A and C]). The GFP-Ttll6Ap-overexpressing cells maintained short hyperglutamylated cilia even 4 h after deciliation (3.88 ± 0.89 μm, n = 82; wild-type cells 5.43 ± 0.59 μm, n = 60 [Fig. 5B, D, and G]).
The failed elongation of regenerating cilia in cells overproducing GFP-Ttll6Ap could be caused either by the physical presence of GFP-Ttll6Ap or by tubulin hyperglutamylation. To distinguish between these two effects, we compared the lengths of cilia in Tetrahymena cells overexpressing either an enzymatically active and cilium-targeted enzyme (GFP-Ttll6Ap-M241-V929) or an inactive enzyme with an amino acid substitution in the ATP-binding site (GFP-Ttll6Ap-M241-V929-E662G ). Whereas cells overproducing an active enzyme regenerated excessively short axonemes (1.44 ± 0.49, n = 62, after 2 h [Fig. 5F and G]), cells overexpressing an inactive enzyme assembled normal length axonemes (5.05 ± 0.59 μm, n = 40, after 2 h [Fig. 5E and G]) despite the fact that the inactive enzyme is targeted to cilia (22). Cells overexpressing GFP-M241-Q828 that localizes mainly to cell bodies, regenerated cilia at the rate similar to that of wild-type cells (see Fig. S5 in the supplemental material). Thus, most likely, the inhibitory effect of GFP-Ttll6Ap on the elongation of axonemes is mediated by hyperelongation of glutamyl side chains on axonemal tubulin.
The TEM analysis of vegetatively growing cells overproducing GFP-Ttll6Ap (Fig. (Fig.6)6) revealed two types of axonemes: unaffected 9+2 axonemes and structurally defective mostly 9+0 axonemes. The intact 9+2 axonemes are likely present in the nonassembling cilia that do not accumulate GFP-Ttll6Ap. The defective axonemes frequently lacked a central pair (Fig. 6A to C) and had broken outer doublets (Fig. 6E and F). These observations indicate that, in GFP-Ttll6Ap-overproducing cells, assembling axonemes are unstable.
In an attempt to probe how the dynamic properties of axonemal microtubules change as a function of glutamyl side chain hyper-elongation, we treated control and GFP-Ttll6Ap-overproducing cells with 40 μM paclitaxel for 3 h. As previously described in wild-type cells (54), paclitaxel increased the average axoneme length by 20% (length before treatment, 5.02 ± 0.52 μm, n = 129; length after treatment, 6.05 ± 1.12 μm, n = 173 [Fig. 7A to C]). In GFP-overproducing cells, the assembling cilia were 44% longer in the presence of paclitaxel compared to non-drug-treated GFP-Ttll6Ap-overproducing cells (no drug, 1.87 ± 0.36 μm; paclitaxel treated, 2.7 ± 0.6 μm [Fig. 7D to F]). Furthermore, the assembling cilia in GFP-Ttll6Ap-overproducing, paclitaxel-treated cells had elevated levels of tubulin polyglutamylation comparable to those in axonemes of the untreated GFP-Ttll6Ap-overproducing cells. The simplest explanation of these observations is that hyperelongation of glutamyl side chains on the tubulin of assembling axonemal microtubules makes them unstable and that this effect can be counteracted by paclitaxel. Interestingly, in GFP-Ttll6Ap-overexpressing paclitaxel-treated cells, preexisting cilia underwent elongation by 22% by forming a hyperglutamylated distal segment (before treatment, 5.25 ± 0.5 μm; paclitaxel treated, 6.39 ± 0.82 μm [Fig. 7E and F, arrows]). In wild-type cells treated with paclitaxel the distal segments of preexisting elongated axonemes had lower levels of tubulin polyglutamylation compared to the preexisting proximal axoneme segment (see Fig. S6 in the supplemental material). This argues again that the destabilizing effects of hyperglutamylation in the axoneme are counteracted by paclitaxel.
The polymeric character of glycylation and glutamylation, as well as the fact that these PTMs affect multiple modification sites within the tubulin CTTs and can coexist on the same tubulin proteins, generates an exceptionally large number of tubulin isoforms. The polymodification sites on β-tubulin are required for axoneme assembly (49). Functional studies on the E- and G-ligases indicate that both glutamylation and glycylation on tubulin are important and contribute to either the assembly or the stability of microtubules, including those present in neural extensions (20), and axonemes (33, 38, 54). However, it is not known what the structural consequences of tubulin polymodifications on microtubules are.
The length of the polymodification side chain is spatially regulated and dependent on the microtubule type and possibly on the position of tubulin subunits within the microtubule (8, 53). Moreover, in multicellular organisms, the glutamyl side chain length changes during organismal development (3, 20). Among the mechanisms that regulate the side chain length could be (i) temporal and spatial regulation of the initiation and elongation steps performed by E-ligases and (ii) selective shortening of glutamyl side chain by deglutamylases (3). Whereas some E-ligases, such as the murine TTLL7, can both initiate and elongate the side chains (32), the majority of studied E-ligases have a bias for either chain elongation or initiation (22, 50, 53). Ttll6Ap is a strong elongase for β-tubulin (50; the present study). We have studied here the consequences of hyperelongation of glutamyl side chain in vivo by overexpressing Ttll6Ap. Although the activity mediated by GFP-Ttll6Ap on the nonciliary microtubules could be nonphysiological, this ectopic activity gave us a tool to investigate the importance of the side chain length regulation on multiple types of microtubules within the same cell.
We show that the consequences of overexpression of Ttll6Ap depend on the cellular context. Hyperelongation of glutamyl side chains on cell body microtubules increased the density and bundling of microtubules, resistance to depolymerizing drugs, and α-tubulin K40 acetylation. These effects are consistent with an increased stability of hyperglutamylated cell body microtubules. In wild-type Tetrahymena cells, the most dynamic microtubules (e.g., the cytoplasmic network, micronuclear spindle, and macronuclear and longitudinal cortical microtubules) have tubulin subunits with side chains limited to monoglutamylation (8, 53). In contrast, basal bodies and axonemes have elongated glutamyl side chains, and these microtubules are known to be extremely stable (turnover slowly and resist standard depolymerizing treatments) (48). We speculate that the physiological elongation of glutamyl side chains on tubulin of basal body and axonemal microtubules contributes to their increased stability. Indeed, deletion of some TTLL6 genes led to shortening of axonemes (Suryavanshi and Gaertig, unpublished). In GFP-Ttll6Ap-overproducing cells, hyperelongation of the cell body microtubules could lead to capture of axoneme-stabilizing MAPs that are in transit to cilia. A model that elongation of the glutamyl side chains stabilizes microtubules by recruiting MAPs likely applies to other contexts. In neurons, the accumulation of tubulin polyglutamylation during differentiation correlates with increased stability of microtubules and the accumulation of MAP2 in dendrites and the cell body (20). Moreover, knockdown of TTLL7 E-ligase inhibited the formation of MAP2-positive neurites in PC-12 cells (20). In vitro studies show that the levels of tubulin glutamylation affect the binding of certain structural MAPs and motor proteins to microtubules (6, 7, 19, 27). Future studies in vitro based on microtubule polyglutamylation with purified E-ligases should shed light on the mechanism of polyglutamylation-induced microtubule stabilization and, in particular, should reveal whether polyglutamylation has a direct effect on the microtubule dynamics or acts via MAPs.
Given the apparent stabilizing effect of the hyperelongation of glutamyl side chains on the cell body microtubules and the fact that native axonemes have relatively long glutamyl side chains, it was surprising that we observed a seemingly opposite effect of hyperglutamylation on axonemes. It appears that the destabilizing effects of overexpressed Ttll6Ap on axonemes are largely autonomous and cannot be explained by the retention of stabilizing axoneme-destined MAPs in the cell body. The shortening of axonemes could be explained by inhibition of the intraflagellar transport (IFT) pathway, a motility mechanism that moves precursors required for cilia assembly along growing outer doublet microtubules (26). However, the defect in the elongation of axonemes in GFP-Ttll6Ap cells is partly rescuable by paclitaxel, suggesting that the elongation of glutamyl side chains destabilizes axonemal microtubules. Moreover, paclitaxel failed to rescue an axoneme assembly defect caused by a loss of function of IFT in the DYF1 knockout strain of Tetrahymena (12; unpublished data).
Hyperelongation of glutamyl side chains on tubulin could affect the dynamics of microtubules. This model agrees with the observation that the removal of CTTs by proteolysis with subtilisin increases the resistance of microtubules to depolymerization by high salt and cold (4, 41), although other studies disagree with this conclusion (25, 42). CTTs are highly negatively charged and could interact with the positively charged surface of the tubulin dimer (35). Glutamylation further increases the negative charge of CTTs. The bonds between the dimers could be weakened by charge repulsion, especially if CTTs of neighboring tubulin subunits can interact with each other. However, we would need to assume that in GFP-Ttll6Ap-overproducing cells, and specifically in the cell body, the lattice-weakening effects of glutamylation are counteracted by stabilizing MAPs that preferentially bind to hyperglutamylated microtubules.
Alternatively, the restriction of the destabilizing effect of hyperglutamylation to the axoneme could result from differential utilization of tubulin subunits. In vitro studies showed that Ttll6Ap prefers β-tubulin (22), but the same enzyme, when overexpressed in vivo, modified both α- and β-tubulin (Fig. (Fig.1C).1C). Thus, some differences in the consequences of excessive activity of Ttll6Ap could result from the differential utilization of α- and β-tubulin subunits in different microtubules, which in turn could be caused by competing MAPs that selectively hinder one of the two tubulin subunits.
However, another explanation of the restriction of destabilizing influence of hyperglutamylation to axonemes is that this effect is mediated by axoneme-restricted factors that are regulated by polyglutamylation. Specifically, in assembling axoneme, hyperelongation of glutamyl side chains could increase the activity of factors that promote microtubule depolymerization. A microtubule-severing protein, katanin, plays a prominent role in the axoneme assembly. Katanin localizes to cilia in Tetrahymena and Chlamydomonas (13, 46). The presence of CTTs is required for the katanin-mediated microtubule-severing activity in vitro (30). Knockouts of katanin subunit genes in Tetrahymena phenocopy the substitutions of glutamic acids that undergo polymodifications in the CTT of β-tubulin (46). The activity of spastin, another microtubule-severing protein, is blocked by an antibody that recognized a terminal glutamic acid, a finding consistent with a requirement of either detyrosination or polyglutamylation (or both) for severing activity (39). In the axoneme, tubulin hyperglutamylation could cause an excessive activity of severing factors such as katanin, specifically during axoneme assembly, and this could prevent axoneme elongation and assembly of central microtubules. Interestingly, the levels of tubulin glutamylation appear to change during axoneme assembly in wild-type cells. The short assembling cilia label more strongly with antibodies that recognize elongated glutamyl side chains. The signal of polyglutamylation decreases as cilia mature, while the levels of polyglycylation increase in these cilia (46). Thus, axonemal microtubules undergo remodeling of the PTM composition as part of the polymer maturation. It is possible that some glutamyl side chains are trimmed down or completely removed by deglutamylating enzymes (2) and are replaced by glycyl side chains. Thus, tubulin glutamylation could play distinct roles during and after assembly of the axoneme. In a growing axoneme, tubulin polyglutamylation could promote polymer turnover, whereas in the mature axoneme the modification could contribute to increased stability of the polymer.
To summarize, we show that the effects of tubulin hyperglutamylation are subcellular context specific. In the same cells, hyperglutamylation stabilizes cell body microtubules and destabilizes axonemes. We propose that the differential effects of hyperglutamylation are mediated by nonuniformly distributed MAPs.
This study was supported by the National Science Foundation (MBC-033965 to J.G.).
We are grateful to the following researchers for providing reagents: Martin A. Gorovsky (University of Rochester) for poly(E) antibodies, Joseph Frankel (University of Iowa) for MAb 12G10 (available from the Developmental Studies Hybridoma Bank), Marie-Helene Bré for TAP952 MAb, and Klaus Weber (Max Planck Institute, Goettingen, Germany) for MAb ID5.
Published ahead of print on 21 August 2009.
†Supplemental material for this article may be found at http://ec.asm.org/.